<img alt="" height="1" width="1" />
Why The New Dendreon Analysis Does Matter — And Why It Doesn't
Forbes (blog)
Last night, a researcher from Duke University presented an analysis that may help cement the case that Dendreon's Provenge extends the lives of men with metastatic prostate cancer – if, that is, you think additional proof is needed. ...
Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary ...PR Newswire (press release)
Dendreon: Make or Break Year for ProvengeSeeking Alpha
Dendreon Adds Ammo to Provenge DefenseMinyanville.com
all 25 news articles »
More...